NCT07042100
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07042100
Title A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sun Pharma Advanced Research Company Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Honorhealth Research Institute RECRUITING Scottsdale Arizona 85258 United States Details
Sarcoma Oncology Research Center RECRUITING Santa Monica California 90403 United States Details
Yale University - Yale Cancer Center NOT_YET_RECRUITING New Haven Connecticut 06510 United States Details
Hope And Healing Cancer Services, Llc RECRUITING Hinsdale Illinois 60521 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Scientia Clinical Research RECRUITING Randwick New South Wales 2031 Australia Details
Sunshine Coast University Private Hospital RECRUITING Birtinya Queensland 4557 Australia Details
Cancer Research South Australia RECRUITING Adelaide South Australia 5000 Australia Details
Tata Memorial hospital NOT_YET_RECRUITING Mumbai Maharashtra 400012 India Details
Noble Hospital Pvt. Ltd. RECRUITING Pune Maharashtra 411013 India Details
All India Institute for Medical Sciences RECRUITING Delhi New Delhi 110029 India Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field